GlassScriptPhysician profile
Joanna K Chon
NPI 1477602068
$9,147.83
in general payments reported to CMS, 2019-2025
44 companies · $3,872 in 2025
The $3,872 reported for 2025 was more than what 81% of Urogynecology and Reconstructive Pelvic Surgery (Urology) providers received nationally (typical 2025 total: $782).
See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $337 · 2021: $1,789 · 2022: $674 · 2023: $1,390 · 2024: $596 · 2025: $3,872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,091 · Travel and Lodging: $513 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,090.98 |
| Travel and Lodging | $513.21 |
| Education | $253.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,330.77 | 2020-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $986.82 | 2019-2025 | Xtandi, Myrbetriq |
| Medtronic, INC. | $636.01 | 2025 | Altaviva |
| Janssen Biotech, INC. | $508.99 | 2021-2025 | Erleada, Rybrevant, Carvykti |
| Coloplast Corp | $448.78 | 2019-2025 | Speedicath, Self-Cath |
| Boston Scientific Corporation | $403.74 | 2025 | Axonics, Spaceoar Vue System - 10ml |
| Ferring Pharmaceuticals INC. | $356.04 | 2025 | Adstiladrin |
| Urogen Pharma, INC. | $334.73 | 2022-2025 | |
| Procept Biorobotics Corporation | $243.24 | 2023-2025 | Aquabeam Robotic System |
| Abbvie INC. | $234.07 | 2022-2025 | Botox |
| Pfizer INC. | $212.15 | 2019-2025 | |
| Tolmar, INC. | $175.69 | 2024-2025 | Eligard, Jatenzo |
| Srs Medical Systems, INC. | $167.29 | 2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Bayer Healthcare Pharmaceuticals INC. | $166.66 | 2022-2025 | |
| Intuitive Surgical, INC. | $156.84 | 2023-2025 | Da Vinci Surgical System |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $149.53 | 2024-2025 | Xiaflex, Aveed, Edex |
| Sumitomo Pharma America, INC. | $136.57 | 2023-2025 | Gemtesa, Orgovyx |
| Allergan, INC. | $131.56 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $124.98 | 2023 | Lynparza |
| Baxter Healthcare | $115.46 | 2023 | Floseal |
| Telix Pharmaceuticals | $115.38 | 2025 | Illuccix |
| Femselect INC. | $109.71 | 2024 | Enplace |
| Caldera Medical, INC | $103.02 | 2023 | Desara |
| Dendreon Pharmaceuticals LLC | $82.62 | 2025 | Provenge |
| Bluewind Medical | $73.02 | 2025 | |
| Laborie Medical Technologies Corp. | $64.75 | 2023-2025 | Aquarius Lt, Urgent PC Neuromodulation System |
| Urovant Sciences INC | $60.28 | 2022 | |
| Novartis Pharmaceuticals Corporation | $59.92 | 2025 | |
| Endo Pharmaceuticals INC. | $59.56 | 2019-2022 | |
| Therapeuticsmd, INC. | $51.80 | 2019-2020 | |
| Blue Earth Diagnostics | $50.02 | 2019-2024 | |
| Bard Access Systems, INC. | $41.88 | 2019 | |
| Becton, Dickinson and Company | $34.77 | 2025 | Bard Urinary Drainage Bag |
| Ambu INC. | $26.06 | 2021 | |
| Abbott Laboratories | $25.03 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $24.76 | 2025 | Lynparza |
| Verity Pharmaceuticals INC. | $22.10 | 2025 | Trelstar |
| Kerecis Limited | $20.75 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Baudax Bio INC. | $19.92 | 2021 | |
| Antares Pharma, INC. | $18.45 | 2025 | Xyosted |
| Smith+Nephew, INC. | $17.70 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $16.60 | 2023 | Seglentis |
| Duchesnay USA Incorporated | $15.94 | 2019 | |
| Teleflex LLC | $13.87 | 2025 | Barrigel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Chon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.